Market Jar reports on market events, the hottest news in every market sector, and early investment opportunities for investors interested in small- and mid-cap opportunities.
No link added
Groundbreaking therapies that could change the treatment landscape for PTSD, fibromyalgia, MS & Alzheimer’s
Key Takeaways Silo Pharma is advancing a diversified pipeline of innovative therapies aimed at major health challenges in Central Nervous System (CNS) disorders like PTSD, fibromyalgia, Alzheimer’s, and multiple sclerosis (MS). The company’s unique approach of combining traditional drugs with psychedelic-inspired therapies positions it to address significant gaps in the treatment landscape.Read more
The Next Phase of Defense AI: A Robotic Response to America’s Security Gaps
Autonomous systems are no longer just a futuristic vision — they’re fast becoming an essential layer of national security. As AI reshapes everything from finance to warfare, physical security remains one of the most under-addressed frontiers.Read more
The Next Phase of Energy Storage: How NeoVolta Is Tackling America’s Power Crunch
Battery storage is no longer a niche corner of clean tech. It’s emerging as the backbone of America’s energy future.Read more